Clinical trials

Condition   Drug Name  
Study WB-1001 in psoriasis
Design Randomized
Patients 36
Treatment Regimen WB-1001 [cream] top. o.d; WB-1001 [cream] top. b.i.d.; Placebo
Conclusions A phase I study was started to evaluate the safety and best dose of topical WB-1001 cream in patients with psoriasis
Reference(s) Phase I clinical trial underway for Welichem Biotech
Welichem Biotech Press Release 2007